The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

President Joe Biden’s fiscal 2024 budget proposes allowing Medicare to negotiate drug prices more quickly after new medicines are approved and increasing the number of drugs subject to price ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

Drug price negotiation had been prohibited since Medicare coverage of prescription drugs was first authorized. The law that created the benefit, signed by President George W. Bush in 2003, ...

The Biden administration unveiled Tuesday the names of the first 10 drugs subject to price negotiations in Medicare, including several popular blood thinners and diabetes medications.

Medicare drug price negotiation. The first 10 drugs. Major blood thinners and diabetes drugs made the cut for the initial round. Winners and losers.

Price negotiations will of course not completely erase spending on drugs subject to negotiation and their competitors. The ultimate savings will depend on how successfully Medicare negotiates prices.

The Congressional Budget Office projects the drug price negotiations will save the federal health program $98.5 billion over one decade. Free vaccines and $35 monthly insulin.

Medicare announced the first 10 prescription drugs that will be subject to price negotiation to lower drug costs. Popular — and pricey — blood thinners and diabetes drugs are on the list.

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list.